Beijing Shunxi Fund
Beijing, Beijingbscomc.com
Overview
Beijing Shunxi Private Equity Fund Management Co., Ltd. (Shunxi Fund) is a private equity and venture capital firm that operates as a subsidiary of Beijing State-owned Capital Operation and Management (北京国管). Established in 2015, the firm manages several funds and focuses on early-stage technology investments. Its key investment areas include healthcare, advanced manufacturing, smart hardware, and enterprise services. The firm actively engages in the pharmaceutical and health sectors, managing a Beijing municipal-level industry fund and pursuing M&A opportunities.
Portfolio Companies
4
Website
bscomc.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Moonshot AI | May 2026 | Series D | Co-investor |
| Vivacta Biotechnology (Shanghai) Co., Ltd. | Apr 2026 | Series A | Co-investor |
| SpacemiT | Jan 2026 | Series B | Co-investor |
| PixVerse | Oct 2025 | Series B Extension | Co-investor |
| SpacemiT | Aug 2023 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
